| Indoco Remedies Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532612 |
NSE Symbol : INDOCO |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE873D01024 |
Div & Yield% : 0.08 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 118.20 |
Market Cap(₹Cr) : 2,262.38 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 429.30 | 383.83 | 341.07 | 364.91 | 394.58 | 394.22 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 429.30 | 383.83 | 341.07 | 364.91 | 394.58 | 394.22 |
| Other Operating Income | 12.82 | 8.70 | 6.18 | 8.07 | 1.95 | 7.21 |
| Other Income | 6.54 | 5.58 | 6.50 | 5.25 | 4.20 | 3.52 |
| Total Income | 448.66 | 398.11 | 353.75 | 378.23 | 400.73 | 404.95 |
| Total Expenditure | 389.26 | 377.70 | 343.79 | 352.84 | 343.66 | 349.86 |
| PBIDT | 59.40 | 20.41 | 9.96 | 25.39 | 57.07 | 55.09 |
| Interest | 22.01 | 23.61 | 15.98 | 14.00 | 14.77 | 11.88 |
| PBDT | 37.39 | -3.20 | -6.02 | 11.39 | 42.30 | 43.21 |
| Depreciation | 27.63 | 25.20 | 24.88 | 24.75 | 24.92 | 23.70 |
| Tax | 0.00 | 0.00 | -2.93 | -5.04 | 3.24 | 4.73 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -5.29 | -0.34 | -1.73 | 1.91 | 1.35 | -0.17 |
| Reported Profit After Tax | 15.05 | -28.06 | -26.24 | -10.23 | 12.79 | 14.95 |
| Extra-ordinary Items | -0.53 | 0.00 | 0.00 | 0.85 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 15.58 | -28.06 | -26.24 | -11.08 | 12.79 | 14.95 |
| EPS (Unit Curr.) | 1.63 | -3.04 | -2.85 | -1.11 | 1.39 | 1.62 |
| EPS (Adj) (Unit Curr.) | 1.63 | -3.04 | -2.85 | -1.11 | 1.39 | 1.62 |
| Calculated EPS (Unit Curr.) | 1.63 | -3.04 | -2.84 | -1.11 | 1.39 | 1.62 |
| Calculated EPS (Adj) (Unit Curr.) | 1.63 | -3.04 | -2.84 | -1.11 | 1.39 | 1.62 |
| Calculated EPS (Ann.) (Unit Curr.) | 6.53 | -12.17 | -11.38 | -4.44 | 5.55 | 6.49 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 6.53 | -12.17 | -11.38 | -4.44 | 5.55 | 6.49 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 18.45 | 18.45 | 18.45 | 18.44 | 18.44 | 18.44 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 13.84 | 5.32 | 2.92 | 6.96 | 14.46 | 13.97 |
| PBDTM(%) | 8.71 | -0.83 | -1.77 | 3.12 | 10.72 | 10.96 |
| PATM(%) | 3.51 | -7.31 | -7.69 | -2.80 | 3.24 | 3.79 |